Skip to content
healthcare.dev
Get a free key

Rinvoq

NDC 0074-1043, Upadacitinib, tablet, extended release, from AbbVie Inc..

Product NDC
0074-1043
Status
Listed
Labeler
AbbVie Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211675
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1043 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • UPADACITINIB45 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0074-1043-140007410431414 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14)
0074-1043-280007410432828 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2966aec7-2ef0-923c-d8ff-fe1a957bf095

  • NADAC price for package 00074104328

    GET /v1/drugs/nadac/00074104328

Use it

Look up 0074-1043 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1043 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-1043. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.